WELCOME TO BIOSENSORS

our news

BioFreedom proven in LEADERS FREE for Ultra-short DAPT

August 31, 2018 | News | BioFreedom
Freedom to treat with 1 month DAPT - Proven for ultra-short DAPT in the LEADERS FREE study, BioFreedom was more safe and effective than a BMS in high bleeding risk patients
READ MORE

HIGH BLEEDING RISK PATIENTS

January 20,2010 | News | BioFreedom
BioFreedom is the only active stent with CE mark for ultra-short 1 month DAPT, in High bleeding Risk (HBR) patients, supported by clinical data from a double-blind randomized controlled trial.
READ MORE

CARDIAC DEATH IN ACS?

March 20, 2019 | News | BioMatrix+BioFreedom
Can you find any other stent ?...
…that significantly reduces Cardiac Death vs. another DES in STEMI?
…that significantly reduces Cardiac Death vs. BMS in HBR ACS patients?
READ MORE

INNOVATIVE TECHNOLOGIES